Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis von Luo, Wenjing, Li, Chenggong, Zhang, Yinqiang, Du, Mengyi, Kou, Haiming, Lu, Cong, Mei, Heng, Hu, Yu

Volltext

Mutations in the DNA methylation pathway predict clinical efficacy to hypomethylating agents in myelodysplastic syndromes: a meta-analysis von Du, Mengyi, Zhou, Fen, Jin, Runming, Hu, Yu, Mei, Heng

Volltext

Biomarkers in individualized management of chimeric antigen receptor T cell therapy von Du, Mengyi, Hari, Parameswaran, Hu, Yu, Mei, Heng

Volltext

Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma von Du, Mengyi, Huang, Linlin, Kou, Haiming, Li, Chenggong, Hu, Yu, Mei, Heng

Volltext

Timing of Tocilizumab Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia von Zhang, Yinqiang, Zhou, Fen, Wu, Zhuolin, Li, Yingnan, Li, Chenggong, Du, Mengyi, Luo, Wenjing, Kou, Haiming, Lu, Cong, Mei, Heng

Volltext

Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies von Zhang, Yinqiang, Li, Chenggong, Du, Mengyi, Jiang, Huiwen, Luo, Wenjing, Tang, Lu, Kang, Yun, Xu, Jia, Wu, Zhuolin, Wang, Xindi, Huang, Zhongpei, Zhang, Yanlei, Wu, Di, Chang, Alex H., Hu, Yu, Mei, Heng

Volltext

Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma von Li, Chenggong, Zhou, Fen, Wang, Jing, Chang, Qi, Du, Mengyi, Luo, Wenjing, Zhang, Yinqiang, Xu, Jia, Tang, Lu, Jiang, Huiwen, Liu, Lin, Kou, Haiming, Lu, Cong, Liao, Danying, Wu, Jianghua, Wei, Qiuzhe, Ke, Sha, Deng, Jun, Liu, Cheng, Mei, Heng, Hu, Yu

Volltext

Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients von Zhou, Fan, Zhou, Fen, Du, Mengyi, Liu, Lin, Guo, Tao, Xia, Linghui, Jin, Runming, Hu, Yu, Mei, Heng

Volltext

Financial Fraud Transaction Prediction Approach Based on Global Enhanced GCN and Bidirectional LSTM von Chen, Yimo, Du, Mengyi

Volltext

Plasma proteomic and metabolomic signatures of B‐ALL patients during CAR‐T cell therapy von Wu, Jianghua, Tang, Lu, Du, Mengyi, Li, Chenggong, Kou, Haiming, Jiang, Huiwen, Luo, Wenjing, Zhang, Yinqiang, Huang, Zhongpei, Liao, Danying, Xiong, Wei, Mei, Heng, Hu, Yu

Volltext

Targeting autophagy overcomes cancer‐intrinsic resistance to CAR‐T immunotherapy in B‐cell malignancies von Tang, Lu, Zhang, Huan, Zhou, Fen, Wei, Qiuzhe, Du, Mengyi, Wu, Jianghua, Li, Chenggong, Luo, Wenjing, Zhou, Jie, Wang, Xindi, Chen, Zhaozhao, Zhang, Yinqiang, Huang, Zhongpei, Wu, Zhuolin, Wen, Yuxi, Jiang, Huiwen, Liao, Danying, Kou, Haiming, Xiong, Wei, Mei, Heng, Hu, Yu

Volltext

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis von Luo, Lili, Luo, Ting, Du, Mengyi, Mei, Heng, Hu, Yu

Volltext

Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia von Tang, Lu, Wu, Jianghua, Li, Cheng-Gong, Jiang, Hui-Wen, Xu, Min, Du, Mengyi, Yin, Zhinan, Mei, Heng, Hu, Yu

Volltext

Long-Term Follow-up of Humanized and Murine CD19 CAR-T Cell Therapy for B-Cell Malignancies von Zhang, Yinqiang, Du, Mengyi, Liao, Danying, Xie, Wei, Xiong, Wei, Mei, Heng

Volltext

Comparison of the Three Scoring Systems— Ipss、Wpss、and IPSS-R in Predicting the Prognosis of MDS in Chinese von Du, Mengyi, Mei, Heng, Hu, Yu

Volltext

Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe von Wei, Qiuzhe, Wang, Jing, Shi, Wei, Zhang, Bo, Jiang, Huiwen, Du, Mengyi, Mei, Heng, Hu, Yu

Volltext

A Multicompartment Mathematical Model Based on Host Immunity for Dissecting COVID-19 Heterogeneity von Wu, Jianghua, Mei, Heng, Li, Jianwei, Zhang, Jingpeng, Tang, Lu, Du, Mengyi, Li, Fangting, Hu, Yu

Volltext

Single-Cell Analyses Identify Transcriptional Characterizations of Subsets Associated with Efficacy and Toxicity for CAR-T Immunotherapy in B-ALL Patients von Du, Mengyi, Mei, Heng, Li, Chenggong, Zhang, Yinqiang, Tang, Lu, Wu, Jianghua, Kou, Haiming, Hu, Yu

Volltext

Infectious Complications Following Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancy von Li, Yingnan, Mei, Heng, Du, Mengyi, Li, Chenggong, Zhang, Yinqiang, Luo, Wenjing, Kou, Haiming, Hu, Yu

Volltext

Timing of Tocilizumab and Corticosteroids Administration Under the Guidance of IL-6 in CAR-T Therapy for R/R Acute Lymphoblastic Leukemia von Zhang, Yinqiang, Mei, Heng, Li, Chenggong, Li, Yingnan, Du, Mengyi, Luo, Wenjing, Tang, Lu, Wu, Jianghua, Xia, Linghui, Hu, Yu

Volltext